<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04597138</url>
  </required_header>
  <id_info>
    <org_study_id>20-002573</org_study_id>
    <nct_id>NCT04597138</nct_id>
  </id_info>
  <brief_title>Deep Venous Thrombus Characteristics and Venous Dynamics With Subsequent Thrombus Resolution and Post-thrombotic Syndrome</brief_title>
  <official_title>The Relationship Between Deep Venous Thrombus Characteristics and Venous Dynamics With Subsequent Thrombus Resolution and Post-thrombotic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to examine in vivo thrombosis characteristics with ultrasound shear&#xD;
      wave elastography (SWE) and determine the relationship with thrombus resolution and&#xD;
      postthrombotic syndrome (PTS) in patients with acute proximal Deep Vein Thrombosis (DVT).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Thrombus Resolution</measure>
    <time_frame>3 Months after diagnosis of DVT.</time_frame>
    <description>Ultrasound images of lower extremity DVTs comparing the initial diagnostic image of thrombus to a subsequent study performed after 3 months of anticoagulation.The lower extremity venous system is divided into 12 segments. Each vein segment will be analyzed on initial ultrasound and recorded 0 (no DVT), 1 (non-occlusive DVT), or 2 (occlusive DVT). The follow up ultrasound will be analyzed per vein segment and recorded as no residual thrombus, minimal chronic post-thrombotic changes, &gt; 50% resolution, &lt; 50% resolution, near occlusive DVT, no change, and progressive DVT.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-thrombotic syndrome</measure>
    <time_frame>6 months after diagnosis of DVT</time_frame>
    <description>Measured using the Villalta Score. Scale 0-33 with higher values indicating more severe symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vein Specific Quality of Life</measure>
    <time_frame>6 months after diagnosis of DVT</time_frame>
    <description>Measured using The Venous Insufficiency Epidemiological and Economic Study (VEINES) QOL survey. Scores range from 0-100 with higher scores indicating better quality of life.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Post-thrombotic syndrome</measure>
    <time_frame>3 and 12 months after diagnosis of DVT</time_frame>
    <description>Measured using the Villalta Score. Scale 0-33 with higher values indicating more severe symptoms.</description>
  </other_outcome>
  <other_outcome>
    <measure>Vein Specific Quality of Life</measure>
    <time_frame>3 and 12 months after diagnosis of DVT</time_frame>
    <description>Measured using The Venous Insufficiency Epidemiological and Economic Study (VEINES) QOL survey. Scores range from 0-100 with higher scores indicating better quality of life.</description>
  </other_outcome>
  <other_outcome>
    <measure>Thrombus Resolution</measure>
    <time_frame>3 Months after diagnosis of DVT.</time_frame>
    <description>Measured quantitatively by outflow parameters on air plethysmography with expelled volume measured at 1 second x 60 sec (ml/100ml/minute), expelled volume after 4 seconds, and maximum volume expelled.</description>
  </other_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Deep Vein Thrombosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute, proximal DVT initiating anticoagulation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of acute, proximal (popliteal and above) DVT with or without Pulmonary&#xD;
             Embolism within 72 hours&#xD;
&#xD;
          -  â‰¥18 Years Old&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  prior episode of DVT&#xD;
&#xD;
          -  contraindication to standard therapeutic anticoagulation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Damon Houghton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brakha Tabi Zerbib</last_name>
    <phone>507-266-5179</phone>
    <email>Tabi.Brakha@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Trevor Stromme, CCRP</last_name>
    <phone>507-293-2754</phone>
    <email>Stromme.Trevor@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brakha Tabi Zerbib</last_name>
      <phone>507-266-5179</phone>
      <email>tabi.brakha@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Damon Houghton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2020</study_first_posted>
  <last_update_submitted>November 13, 2020</last_update_submitted>
  <last_update_submitted_qc>November 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Damon E. Houghton</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Thrombus Resolution</keyword>
  <keyword>Post-Thrombotic Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
    <mesh_term>Postthrombotic Syndrome</mesh_term>
    <mesh_term>Postphlebitic Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

